EMILIO JOSE
LENCE QUINTANA
Investigador no período 2013-2018

Juan Carlos
Vázquez Ucha
Publicacións nas que colabora con Juan Carlos Vázquez Ucha (8)
2025
-
Advancements in the fight against globally distributed OXA-48 carbapenemase: evaluating the new generation of carbapenemase inhibitors
Antimicrobial Agents and Chemotherapy, Vol. 69, Núm. 2
2024
-
Novel Penicillin-Based Sulfone-Siderophore Conjugates for Restoring β-Lactam Antibiotic Efficacy
ACS Omega, Vol. 9, Núm. 24, pp. 26484-26494
2023
-
Antimicrobial Activity of Cefiderocol against the Carbapenemase-Producing Enterobacter cloacae Complex and Characterization of Reduced Susceptibility Associated with Metallo-β-Lactamase VIM-1
Antimicrobial agents and chemotherapy, Vol. 67, Núm. 5, pp. e0150522
-
In vitro development of imipenem/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modification
International Journal of Antimicrobial Agents, Vol. 62, Núm. 4
2021
-
6-Halopyridylmethylidene Penicillin-Based Sulfones Efficiently Inactivate the Natural Resistance of Pseudomonas aeruginosa to β-Lactam Antibiotics
Journal of Medicinal Chemistry, Vol. 64, Núm. 9, pp. 6310-6328
2020
-
Molecular and biochemical insights into the in vivo evolution of AmpC-mediated resistance to ceftolozane/tazobactam during treatment of an MDR Pseudomonas aeruginosa infection
The Journal of antimicrobial chemotherapy, Vol. 75, Núm. 11, pp. 3209-3217
2019
-
Challenging antimicrobial susceptibility and evolution of resistance (oxa-681) during treatment of a long-term nosocomial infection caused by a pseudomonas aeruginosa ST175 Clone
Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 10
2016
-
Targeting the Motion of Shikimate Kinase: Development of Competitive Inhibitors that Stabilize an Inactive Open Conformation of the Enzyme
Journal of Medicinal Chemistry, Vol. 59, Núm. 11, pp. 5471-5487